Dr. Kaylyn Sinicrope, MD
Claim this profileNorton Healthcare
Studies Brain Tumor
Studies Glioblastoma
7 reported clinical trials
11 drugs studied
Area of expertise
1Brain Tumor
SMO positive
PTCH1 positive
H3 K27M positive
2Glioblastoma
IDH negative
MET positive
Affiliated Hospitals
Clinical Trials Kaylyn Sinicrope, MD is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting1 award Phase 210 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
More about Kaylyn Sinicrope, MD
Clinical Trial Related10 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kaylyn Sinicrope, MD has experience with
- OKN-007
- Temozolomide
- Optune®
- SurVaxM
- ONC201
- Abemaciclib
Breakdown of trials Kaylyn Sinicrope, MD has run
Brain Tumor
Glioblastoma
Brain Cancer
Mesial Temporal Sclerosis
Protoplasmic Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kaylyn Sinicrope, MD specialize in?
Kaylyn Sinicrope, MD focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved SMO positive patients, or patients who are PTCH1 positive.
Is Kaylyn Sinicrope, MD currently recruiting for clinical trials?
Yes, Kaylyn Sinicrope, MD is currently recruiting for 3 clinical trials in Louisville Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Kaylyn Sinicrope, MD has studied deeply?
Yes, Kaylyn Sinicrope, MD has studied treatments such as OKN-007, Temozolomide, Optune®.
What is the best way to schedule an appointment with Kaylyn Sinicrope, MD?
Apply for one of the trials that Kaylyn Sinicrope, MD is conducting.
What is the office address of Kaylyn Sinicrope, MD?
The office of Kaylyn Sinicrope, MD is located at: Norton Healthcare, Louisville, Kentucky 40241 United States. This is the address for their practice at the Norton Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.